Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2652-2659

  Chen, Qian ^a   Wade, David ^b   Kurosaka, Kahori ^a   Wang, Zhao Yuan ^a   Oppenheim, Joost J ^a   Yang, De ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOATTRACTANT; FORMYLPEPTIDE; FORMYLPEPTIDE RECEPTOR LIKE 1; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE DERIVATIVE; PERTUSSIS TOXIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DESENSITIZATION; EMBRYO; FROG; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MACROPHAGE; MAMMAL; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 4043156313     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2652     Document Type: Article

References (66)

1. Ganz, T., and R. I. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:41.
2. Lehrer, R. I., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defense. Curr. Opin. Immunol. 11:23.
3. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389.
4. Boman, H. G. 2003. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254:197.
5. Yang, D., O. Chertov, and J. J. Oppenheim. 2001. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell. Mol. Life Sci. 58:978.
6. Scott, M. G., and R. E. W. Hancock. 2002. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407.
7. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Z. Howard, and J. J. Oppenheim. 1999. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525.
8. Yang, D., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069.
9. Biragyn, A., M. Surenhu, D. Yang, P. A. Ruffini, B. A. Haines, E. Klyushnenkova, J. J. Oppenheim, and L. W. Kwak. 2001. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167:6644.
10. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298:1025.
11. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111:1665.
12. Gao, A.-G., S. M. Hakimi, C. A. Mittanck, Y. Wu, B. M. Woemer, M. Stark, D. M. Shah, J. Liang, and C. M. T. Rommens. 2000. Fungal pathogen protection in potato by expression of a plant defensin. Nat. Biotechnol. 18:1307.
13. Wilson, C. L., A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. Lopez-Boado, J. L. Stratman, S. J. Hultgren, L. M. Matrisian, and W. C. Parks. 1999. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113.
14. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454.
15. Moser, C., D. J. Weiner, E. Lysenko, R. Bals, J. N. Weiser, and J. M. Wilson. 2002. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70:3068.
16. Morrison, G., F. Kilanowski, D. Davidson, and J. Dorin. 2002. Characterization of the mouse β defensin 1, Defb1, mutant mouse model. Infect. Immun. 70:3053.
17. Salzman, N. H., D. Ghosh, K. M. Hutmer, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522.
18. Simmaco, M., G. Mignogna, S. Canofeni, R. Miele, M. L. Mangoni, and D. Barra. 1996. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 242:788.
19. Kim, J. B., S. Iwamuro, F. C. Knoop, and J. M. Conlon. 2001. Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris. J. Pept. Res. 58:349.
20. Isaacson, T., A. Soto, S. Iwamuro, F. C. Knoop, and J. M. Conlon. 2002. Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica. Peptides 23:419.
21. Wade, D., A. Silverira, J. Silberring, P. Kuusela, and H. Lankinen. 2000. Temporin antibiotic peptides: a review and derivation of a consensus sequence. Protein Pept. Lett. 7:349.
22. Wade, D., A. Silverira, L. Rollins-Smith, T. Bergman, J. Silberring, and H. Lankinen. 2001. Hematological and antifungal properties of temporin A and a cecropin A-temporin a hybrid. Acta Biochim. Pol. 48:1185.
23. Harjunpaa, I., P. Kuusela, M. T. Smoluch, J. Silberring, H. Lankinen, and D. Wade. 1999. Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett. 449:187.
24. Wade, D., J. Silberring, R. Soliymani, S. Heikkinen, I. Kilpelainen, and P. Kuusela. 2000. Antibacterial activities of temporin A analogs. FEBS Lett. 479:6.
25. Wade, D., J. I. Flock, C. Edlund, I. Lofving-Arvholm, M. Sallberg, T. Bergman, A. Silveria, C. Unson, L. Rollins-Smith, J. Silberring, et al. 2002. Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept. Lett. 9:533.
26. Rollins-Smith, L. A., C. Carey, J. M. Conlon, L. K. Reinert, J. K. Doersam, T. Bergman, J. Silberring, H. Lankinen, and D. Wade. 2003. Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines. Antimicrob. Agents Chemother. 47:1157.
27. Klein, C., J. I. Paul, K. Sauve, K. Schmidt, M. M. Arcangeli, J. Ransom, J. Trueheart, J. P. Manfredi, J. R. Broach, and A. J. Murphy. 1998. Identification of surrogate agonists for human FPRL-1 receptor by autocrine selection in yeast. Nat. Biotechnol. 16:1334.
28. Baek, S. H., J. K. Seo, C. B. Chae, P. G. Suh, and S. H. Ryu. 1996. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J. Biol. Chem. 271:8170.
29. Le, Y., W.-h. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163:6777.
30. Christophe, T., A. Karlsson, C. Dugave, M. J. Rabiet, F. Boulay, and C. Dahlgren. 2001. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276:21585.
31. Yang, D., Q. Chen, B. Gertz, R. He, M. Phulsuksombati, R. D. Ye, and J. J. Oppenheim. 2002. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukocyte Biol. 72:598.
32. Yang, D., Q. Chen, S. Stoll, X. Chen, O. M. Z. Howard, and J. J. Oppenheim. 2000. Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression. J. Immunol. 165:2694.
33. Yang, D., Q. Chen, Y. Le, J. M. Wang, and J. J. Oppenheim. 2001. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 166:4092.
34. Yang, D., H. F. Rosenberg, Q. Chen, K. D. Dyer, K. Kurosaka, and J. J. Oppenheim. 2003. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102:3396.
35. Wade, D., T. Bergman, J. Silberring, and H. Lankinen. 2001. Synthesis and characterization of new temporin A analogs and a hybrid peptide. Protein Pept. Lett. 8:443.
36. Kaslow, H. R., and D. L. Burns. 1992. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 6:2684.
37. Sodhi, A., and S. K. Biswas. 2002. Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation. J. Interferon Cytokine Res. 22:517.
38. Majka, M., J. Ratajczak, M. A. Kowalska, and M. Z. Ratajczak. 2000. Binding of stromal derived factor-1α (SDF-1α) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur. J. Haematol. 64:164.
39. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593.
40. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12:91.
41. 42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21:RC123.
42. Gao, J.-L., H. Chen, J. D. Filie, C. A. Kozak, and P. M. Murphy. 1998. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51:270.
43. Tiffany, H. L., M. C. Lavigne, Y.-H. Cui, J.-M. Wang, T. L. Leto, J.-L. Gao, and P. M. Murphy. 2001. Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276:23645.
44. Hartt, J. K., G. Barish, P. M. Purphy, and J.-L. Gao. 1999. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes: molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190:741.
45. Cui, Y.-H., Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang. 2002. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168:434.
46. Yang, D., A. Biragyn, L. W. Kwak, and J. J. Oppenheim. 2002. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23:291.
47. Huang, H. J., C. R. Ross, and F. Blecha. 1997. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J. Leukocyte Biol. 61:624.
48. 2 production from mast cells. Eur. J. Immunol. 31:1066.
49. Su, S. B., W.-h. Gong, J.-L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395.
50. 4 receptor. J. Exp. Med. 180:253.
51. Perretti, M., N. Chiang, M. La, I. M. Fierro, S. Marullo, S. J. Getting, E. Solito, and C. N. Serhan. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8:1296.
52. Su, S. B., J.-L. Gao, W.-H. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162:5924.
53. 106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166:1448.
54. Betten, A., J. Bylund, T. Cristophe, F. Boulay, A. Romero, K. Hellstrand, and C. Dahlgren. 2001. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Invest. 108:1221.
55. Zhao, C., T. Nguyen, L. M. Boo, T. Hong, C. Espiritu, D. Orlov, W. Wang, A. Waring, and R. I. Lehrer. 2001. RL-37, an α-helical antimicrobial peptide of the rhesus monkey. Antimicrob. Agents Chemother. 45:2695.
56. Bals, R., C. Lang, D. J. Weiner, C. Vogelmeier, U. Welsch, and J. M. Wilson. 2001. Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin. Diagn. Lab. Immunol. 8:370.
57. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
58. Devchand, P. R., M. Arita, S. Hong, G. Bannenberg, R. L. Moussignac, K. Gronert, and C. N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17:652.
59. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197.
60. 4 analogs. J. Clin. Invest. 101:1860.
61. 4 receptor interaction. Biochemistry 34:16678.
62. Serhan, C. N., and B. Levy. 2003. Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem. Immunol. Allergy 83:115.
63. Hancock, R. E. 1999. Host defence (cationic) peptides: what is their future clinical potential? Drugs 57:469.
64. Koczulla, A. R., and R. Bals. 2003. Antimicrobial peptides: current status and therapeutic potential. Drugs 63:389.
65. Paquette, D. W., D. M. Simpson, P. Friden, V. Braman, and R. C. Williams. 2002. Safety and clinical effects of topical histatin gels in humans with experimental gingivitis. J. Clin. Periodontol. 29:1051.
66. Giles, F. J., R. Redman, S. Yazji, and L. Bellm. 2002. Iseganan HCl: a novel antimicrobial agent. Expert Opin. Investig. Drugs 11:1161.